Clarithid Film-Coated Tablets 250 mg (Clarithromycin)

Adult dose

Adults: The usual dose is 250mg (potency) of clarithromycin twice daily. For severe infections, administer 500mg (potency) twice daily. The usual treatment duration is 7～14 days. In patients with renal impairment and a creatinine clearance of 30mL/min or less, the dose should be reduced by half: 250mg (potency) once daily, or, for severe infections, 250mg (potency) twice daily. Do not administer for more than 14 days in these patients. Mycobacterial infections: Administer 500mg (potency) of this medicine twice daily. In this case, it must be administered in combination with other antimycobacterial agents, such as ethambutol, clofazimine, or rifampin. Eradication of Helicobacter pylori in patients with duodenal ulcers: Administer 500mg (potency) of this medicine three times daily with omeprazole 40mg once daily for 14 days, followed by omeprazole 40mg once daily for 14 consecutive days. That is, administer clarithromycin 500mg (potency) three times daily for 14 days (days 1～14) and omeprazole 40mg once daily for 28 days (days 1～28).

Child dose

Children 12 years and older: Same as adults. For children under 12 years, use clarithromycin dry syrup.

This medicine should not be used by patients who are allergic to certain components or who have previously shown hypersensitivity to similar types of antibiotics. It is also advisable for patients with heart arrhythmias, severe liver dysfunction, or for pregnant or breastfeeding women to refrain from taking this medication. This medicine should be given cautiously to patients with liver and kidney impairment or the elderly, and potential interactions may occur when taken with other medications, so consulting a doctor or pharmacist is essential. During treatment, serious allergic reactions or gastrointestinal disturbances, hepatic dysfunction, kidney issues, etc., may occur rarely, so any symptoms should be reported to medical personnel immediately. This medication may lead to hearing problems or neurological symptoms if taken over a long period or in excessive doses, so it is crucial to adhere to the prescribed usage and dosage. Additionally, this medication poses a risk of heart rhythm disturbances or side effects due to increased drug concentration when taken with specific medications, so it is vital to inform health personnel of any other medications being taken. In case of pregnancy or lactation, caution is warranted as it may affect the fetus or infant, and professional guidance should be sought if necessary. Children, elderly patients, and those with kidney or liver dysfunction may require dosage adjustments as per medical instructions. In case of overdose, gastrointestinal disturbances or psychiatric symptoms may occur, necessitating immediate medical attention for appropriate treatment. Finally, this medication should not be administered to patients with specific genetic metabolic disorders, and it should be stored in a sealed container, avoiding sunlight and stored at room temperature.

Shock, anaphylactic symptoms, dyspnea, convulsions, erythema, rash, pruritus, urticaria, skin erythema, angioedema, joint swelling, drug rash, abdominal distension, nausea, vomiting, dyspepsia, abdominal pain, malaise, flatulence, diarrhea, oral mucosal erosion, epigastric pain, thirst, transient tooth discoloration, pancreatitis, increased amylase, dysgeusia, anorexia, constipation, discoloration of stools, membranous colitis, hemorrhagic colitis, abdominal pain, frequent diarrhea, fever, cough, eosinophilic pulmonary infiltrate, interstitial pneumonia, chronic bronchitis, acute maxillary sinusitis, eosinophilia, thrombocytopenia, pancytopenia, hemolytic anemia, leukopenia, agranulocytosis, dizziness, depression, loss of taste, loss of smell, anxiety, insomnia, nightmares, tinnitus, confusion, disorientation, hallucinations, psychosis, depersonalization, convulsions, tremors, numbness, Stevens-Johnson syndrome, toxic epidermal necrolysis, allergic purpura, drug rash, jaundice, hepatocellular hepatitis, cholestatic hepatitis, increased liver enzymes, liver dysfunction, liver failure, fulminant hepatitis, elevated AST, elevated ALT, elevated γ-GTP, elevated LDH, elevated ALP, increased total bilirubin, anorexia, jaundice, dark urine, pruritus, abdominal tenderness, increased serum creatinine, elevated BUN, interstitial nephritis, renal failure, rhabdomyolysis, glossitis, stomatitis, oral candidiasis, QT prolongation, ventricular tachycardia, Torsades de Pointes, malaise, headache, taste alterations, hearing loss, paresthesia, arthralgia, myalgia, olfactory dysfunction, tinnitus, hearing impairment, hypoglycemia, tinnitus, hearing loss, vomiting, purpuric rash, acute generalized exanthematous pustulosis, vasodilation, cardiac arrest, atrial fibrillation, ECG QT prolongation, premature contractions, palpitations, asthma, epistaxis, pulmonary embolism, esophagitis, gastroesophageal reflux disease, gastritis, rectal pain, belching, bloating, acute pancreatitis, tongue discoloration, tooth discoloration, abnormal liver function tests, cholestasis, hepatitis, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated gamma-glutamyltransferase, liver failure, vesicular dermatitis, hyperhidrosis, papular rash, acne, Henoch-Schonlein purpura, muscle cramps, musculoskeletal stiffness, myopathy, elevated blood urea, vein inflammation at injection site, pain at injection site, inflammation at injection site, fever, weakness, chest pain, chills, fatigue, abnormal albumin-globulin ratio, elevated serum alkaline phosphatase, elevated serum lactate dehydrogenase, increased INR, prolonged prothrombin time, abnormal urine color

This medication should be stored in a tightly sealed container, avoiding contact with air and moisture, at a temperature between 1 degrees and 30 degrees Celsius. Doing so helps maintain the medication's effectiveness and prevents degradation.

Appearance

Yellow oval film-coated tablets with a vanilla flavor

Package unit

14 tablets/box[14 tablets(14 tablets/PTPx1)],100 tablets/bottle